Kanda S, Niho S, Kurata T, Nomura S, et al. Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-doublet Chemotherapy for Non-small Cell Lung Cancer Harboring EGFR Mutation. Clin Cancer Res 2025 Mar 31. doi: 10.1158/1078-0432.CCR-24-3532.
PMID: 40162917